ANDA 40471, held by Mylan Institutional. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40471 (Promethazine Hydrochloride), held by Mylan Institutional, was first approved by FDA on Nov 21, 2002, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG/ML ยท injectable;injection | Promethazine Hydrochloride | Discontinued |
| Jun 24, 2005 | Supplement 7Labeling | Approved | None posted |
| Nov 21, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters